Somatostatin receptor imaging of the myocardium with (99m)Tc-depreotide tomography was successfully used in the assessment of a patient with viral myocarditis.
Case Report (n=1)
Can somatostatin receptor imaging with (99m)Tc-depreotide tomography be used to assess myocardial inflammation in a patient with viral myocarditis?
Radiolabeled somatostatin analogue imaging with (99m)Tc-depreotide tomography may serve as a noninvasive tool to delineate inflammatory sites in viral myocarditis.
Myocarditis may present clinically with a wide range of manifestations and often remains unrecognized. The diagnosis of myocarditis traditionally has been based on histological findings, but endomyocardial biopsy has a low sensitivity and clinicians are reluctant to proceed with an invasive diagnostic technique. Among newer diagnostic approaches, cardiac magnetic resonance imaging has gained acceptance as an efficient noninvasive tool to determine myocardial inflammation. In this context, imaging with radiolabeled somatostatin analogues could also be relevant because of their ability to delineate inflammatory sites. In conclusion, a case is presented in which somatostatin receptor imaging of the myocardium with (99m)Tc-depreotide tomography was used in the assessment of viral myocarditis.
Moralidis et al. (Fri,) conducted a case report in Viral myocarditis (n=1). Somatostatin receptor imaging with (99m)Tc-depreotide tomography was evaluated. Somatostatin receptor imaging of the myocardium with (99m)Tc-depreotide tomography was successfully used in the assessment of a patient with viral myocarditis.